EDGAR Filing Documents for 0001193125-22-302262

Form 8-K - Current report:

SEC Accession No. 0001193125-22-302262

Filing Date

2022-12-12

Accepted

2022-12-12 07:39:25

Documents

Period of Report

2022-12-10

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d362658d8k.htm iXBRL	8-K	62286
2	EX-2.1	d362658dex21.htm	EX-2.1	534334
3	EX-2.2	d362658dex22.htm	EX-2.2	25672
4	EX-99.1	d362658dex991.htm	EX-99.1	838608
5	EX-99.2	d362658dex992.htm	EX-99.2	87184
6	EX-99.3	d362658dex993.htm	EX-99.3	21619
7	EX-99.4	d362658dex994.htm	EX-99.4	17874
8	EX-99.5	d362658dex995.htm	EX-99.5	19871
	Complete submission text file	0001193125-22-302262.txt		2128446

Data Files

Seq	Description	Document	Type	Size
9	XBRL TAXONOMY EXTENSION SCHEMA	hznp-20221210.xsd	EX-101.SCH	2887
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	hznp-20221210_lab.xml	EX-101.LAB	17168
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	hznp-20221210_pre.xml	EX-101.PRE	10813
13	EXTRACTED XBRL INSTANCE DOCUMENT	d362658d8k_htm.xml	XML	3294

Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4

Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100

Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)